Added value of dynamic contrast-enhanced MR imaging in deep learning-based prediction of local recurrence in grade 4 adult-type diffuse gliomas patients.

Journal: Scientific reports
Published Date:

Abstract

Local recurrences in patients with grade 4 adult-type diffuse gliomas mostly occur within residual non-enhancing T2 hyperintensity areas after surgical resection. Unfortunately, it is challenging to distinguish non-enhancing tumors from edema in the non-enhancing T2 hyperintensity areas using conventional MRI alone. Quantitative DCE MRI parameters such as K and V convey permeability information of glioblastomas that cannot be provided by conventional MRI. We used the publicly available nnU-Net to train a deep learning model that incorporated both conventional and DCE MRI to detect the subtle difference in vessel leakiness due to neoangiogenesis between the non-recurrence area and the local recurrence area, which contains a higher proportion of high-grade glioma cells. We found that the addition of V doubled the sensitivity while nonsignificantly decreasing the specificity for prediction of local recurrence in glioblastomas, which implies that the combined model may result in fewer missed cases of local recurrence. The deep learning model predictive of local recurrence may enable risk-adapted radiotherapy planning in patients with grade 4 adult-type diffuse gliomas.

Authors

  • Jungbin Yoon
    Department of Radiology, Seoul National University College of Medicine, 101, Daehangno, Jongno-gu, Seoul, 03080, Republic of Korea.
  • Nayeon Baek
    Department of Radiology, Seoul National University College of Medicine, 101, Daehangno, Jongno-gu, Seoul, 03080, Republic of Korea.
  • Roh-Eul Yoo
    Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Seung Hong Choi
    From the Graduate School of Medical Science and Engineering (K.H.K., S.H.P.) and Department of Bio and Brain Engineering (S.H.P.), Korea Advanced Institute of Science and Technology, Room 1002, CMS (E16) Building, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea (S.H.C.); Department of Radiology, Seoul National University College of Medicine, and Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea (S.H.C.); and Center for Nanoparticle Research, Institute for Basic Science, Seoul, Republic of Korea (S.H.C.).
  • Tae Min Kim
    Department of Internal Medicine and Cancer Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Chul-Kee Park
    Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Sung-Hye Park
    Department of Pathology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
  • Jae-Kyung Won
    Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Joo Ho Lee
    Department of Radiation Oncology and Cancer Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Soon Tae Lee
    Department of Neurology, Seoul National University College of Medicine, Seoul, Korea.
  • Kyu Sung Choi
    Graduate School of Medical Science and Engineering, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Ji Ye Lee
    Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Inpyeong Hwang
    Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Koung Mi Kang
    Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Tae Jin Yun
    Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.